Charcot-Marie-Tooth neuronal type 2F (CMT2F) is a rare inherited nerve disease that mainly damages the long nerves of the arms and legs. These nerves control movement and feeling, so people slowly develop weakness, wasting of muscles, and loss of sensation starting in the feet and legs and later in the hands. CMT2F is an “axonal” form of Charcot-Marie-Tooth disease, which means the main problem is in the nerve fiber itself (the axon), not mainly in the myelin coating.National Organization for Rare Disorders+1
CMT2F is caused by harmful changes (mutations) in a gene called HSPB1, which makes a protein called heat shock protein beta-1 (also known as HSP27). This protein helps nerve cells stay healthy during stress. When the gene is changed, the protein does not work properly, so motor and sensory nerves slowly become damaged, especially at their far ends in the feet and hands.PMC+1
In most families, CMT2F is passed in an autosomal dominant way. This means one changed copy of the gene from one parent is enough to cause the disease. Symptoms often begin in teenage years or early adult life but can appear later. The disease usually progresses slowly over many years.MalaCards+1
Other names
Doctors and databases use several other names for this same condition. These names all point to the same or very closely related disease:
-
Charcot-Marie-Tooth disease, axonal, type 2F
-
Charcot-Marie-Tooth disease type 2F (CMT2F)
-
Charcot-Marie-Tooth neuropathy type 2F
-
Charcot-Marie-Tooth neuronal type 2F
-
HSPB1-related CMT2F
-
Autosomal dominant Charcot-Marie-Tooth disease type 2F
These names stress that this is an axonal (type 2) form of CMT and that it is linked to mutations in the HSPB1 gene.MalaCards+1
Types (clinical forms)
Even though there is one main genetic cause (HSPB1 mutation), people with CMT2F can show different “types” or clinical patterns. Doctors sometimes describe them in simple groups:PMC+1
-
Classic sensorimotor CMT2F – both movement and feeling are affected. There is distal leg weakness, foot deformity, and reduced sensation in feet.
-
Motor-predominant CMT2F – weakness and wasting of muscles are the main problem, with only mild or no sensory loss.
-
Early-onset form – symptoms start in childhood or teenage years and may be more severe, with walking problems and foot deformities sooner.
-
Adult-onset form – symptoms start in mid-life, often with slowly progressive foot drop and leg weakness.
-
Late-onset form – symptoms begin after about 50–60 years of age and may progress more mildly.
-
Mild phenotype – very slow progression, minimal disability, sometimes found only when family members are tested.
-
Severe phenotype – stronger weakness, more marked wasting, early need for walking aids.
-
Overlap with distal hereditary motor neuropathy (dHMN) – mainly motor nerve damage with very little sensory loss; still caused by HSPB1 mutation.
-
Phenotype with upper motor neuron signs (rare) – some people can show brisk reflexes and stiffness along with peripheral neuropathy.
-
Biallelic HSPB1-related neuropathy – very rare type where both copies of HSPB1 are mutated, often causing earlier and more severe symptoms.PMC+2PMC+2
Causes
Remember: the true root cause is mutation in the HSPB1 gene. The list below breaks this into detailed “causal” and mechanism-based points to match your requested number, but they all relate to that same genetic problem.
-
Pathogenic HSPB1 mutation – A harmful change in the HSPB1 gene changes the structure of heat shock protein beta-1, making it less able to protect nerve cells from stress. This is the main cause of CMT2F.PMC+1
-
Autosomal dominant inheritance – In most families, one mutated copy of HSPB1 from an affected parent is enough to cause disease in the child. Each child of an affected parent has about a 50% chance to inherit the mutation.MalaCards+1
-
Biallelic (both-allele) HSPB1 mutations – Very rarely, people inherit a mutation from both parents. This can cause a more severe or somewhat different form of CMT2F or related neuropathy.Air
-
De novo HSPB1 mutations – Sometimes the mutation appears for the first time in a person and is not found in either parent. This explains cases with no clear family history.Johns Hopkins University Pure+1
-
Missense mutations in key regions of HSPB1 – Most reported mutations are missense (one amino acid is swapped for another) in important parts of the protein, especially the alpha-crystallin domain and surrounding regions, which are vital for its chaperone function.PMC+1
-
Protein aggregation (clumping) – Mutant HSPB1 can form abnormal clusters inside cells. These aggregates disturb normal cell function and are especially toxic to long motor neurons.PMC+1
-
Disruption of neurofilament network – HSPB1 mutations can disturb the internal “skeleton” of nerve cells. In particular, they can cause abnormal neurofilament build-up and breakdown, which leads to axonal degeneration.MalaCards+1
-
Impaired axonal transport – Long nerves depend on transport of proteins and energy packages along the axon. Mutant HSPB1 can interfere with this transport, so distant parts of the nerve fiber slowly die.Dove Medical Press+1
-
Mitochondrial dysfunction – Studies suggest that some HSPB1 mutations hurt mitochondrial function, so nerve cells cannot make enough energy to keep long axons healthy.Dove Medical Press+1
-
Reduced ability to handle cellular stress – Normal HSPB1 protects proteins from damage during heat, oxidative stress, or other injuries. Mutant HSPB1 does this poorly, so stress builds up and damages nerves over time.PMC+1
-
Interaction with other cytoskeletal proteins – HSPB1 interacts with actin and other cytoskeletal proteins. Mutations can weaken these interactions, which makes axons more fragile.PMC+1
-
Length-dependent vulnerability of distal axons – Because the longest nerves are most sensitive to small defects in transport and energy, the feet and legs are affected first. This “length-dependent” pattern is typical of CMT2F.National Organization for Rare Disorders+1
-
Modifier genes in the background genome – Other genes in a person’s genome may make the HSPB1 mutation’s effect milder or more severe, which explains why different family members can show different levels of disability with the same mutation. This is still under study.PMC+1
-
Age-related cumulative damage – Over years, small axonal injuries add up. Because HSPB1 is not working well, nerves cannot repair themselves efficiently, so symptoms appear and slowly get worse with age.PMC+1
-
Possible environmental stressors (as modifiers, not primary cause) – Things like repeated nerve compression, uncontrolled diabetes, or toxic exposures do not cause CMT2F by themselves, but they may worsen symptoms in someone who already has an HSPB1 mutation.PMC+1
-
Oxidative stress – Experimental work suggests that mutant HSPB1 is less effective at protecting cells from oxidative damage, making nerves more sensitive to free radicals.PMC+1
-
Abnormal interaction with microtubules – HSPB1 helps stabilize microtubules, which are tracks for axonal transport. Mutations may disturb microtubule dynamics, again harming transport in long nerves.PMC+1
-
Altered heat shock response – HSPB1 is part of the broader heat shock protein family. Mutations can change how nerve cells respond to heat or metabolic stress, leaving them less protected.PMC+1
-
Potential dominant-negative effect – Some mutations may not only make the mutated protein faulty but also interfere with the normal copy’s function, amplifying the damage inside neurons.PMC+1
-
Gain-of-toxic-function mechanisms – Many researchers believe that certain HSPB1 mutations give the protein a new toxic function (for example, harmful aggregates or abnormal binding), rather than just losing its normal role. This toxic gain of function is a key proposed cause of CMT2F.PMC+1
Symptoms
CMT2F shares many symptoms with other forms of CMT, but is usually an axonal, distal, slowly progressive neuropathy.ScienceDirect+3Mayo Clinic+3NINDS+3
-
Distal leg weakness – The first and main symptom is weakness in the muscles around the ankles and feet. People may have trouble running, jumping, or walking up stairs.
-
Foot drop – Weakness in the muscles that lift the front of the foot causes the toes to drag. People may lift their knees higher than normal (steppage gait) to avoid tripping.Muscular Dystrophy Association+1
-
High-arched feet (pes cavus) – The arch of the foot becomes very high because some muscles are weak and others pull too strongly. This can cause pressure points, pain, and difficulty finding shoes.Muscular Dystrophy Association+1
-
Hammertoes or claw toes – Short, tight tendons and muscle imbalance pull the toes into a bent position. This can lead to corns, calluses, and discomfort.Mayo Clinic+1
-
Calf muscle wasting – The muscles in the lower leg slowly become thin, giving the appearance of an “inverted champagne bottle” where the calves look skinny compared to the thighs.Mayo Clinic+1
-
Distal hand weakness (later) – After many years, weakness can spread to the hands. People may struggle with buttons, zippers, keys, or writing because of reduced grip and pinch strength.NINDS+1
-
Numbness in feet and toes – Sensation to light touch, pinprick, or temperature in the toes and feet gradually decreases, so people may not feel small injuries or blisters.Mayo Clinic+2NINDS+2
-
Loss of vibration sense – People may not feel a tuning fork vibration at their toes or ankles. This is one of the common sensory losses in length-dependent neuropathy.PMC+1
-
Poor balance, especially in the dark – Because joint position sense in the feet is reduced, it becomes hard to keep balance when the eyes are closed or on uneven ground, leading to unsteady walking and falls.University of Rochester Medical Center+1
-
Reduced or absent ankle reflexes – When the doctor taps the Achilles tendon, there is little or no automatic ankle jerk. This is a typical sign of peripheral neuropathy, including many CMT2F patients.PMC+1
-
Frequent tripping or falls – Because of foot drop, weak ankle stabilizers, and poor sensation, people may trip on small obstacles or stumble on flat ground.Mayo Clinic+1
-
Leg cramps and fatigue – Overworked muscles and abnormal nerve signals can cause cramps, burning, or aching in the legs, especially after walking.NINDS+1
-
Hand deformities (later) – Long-standing weakness in small hand muscles may lead to a “claw hand” posture, with thin hand muscles and difficulty spreading the fingers.ScienceDirect+1
-
Mild neuropathic pain or discomfort – Some people report tingling, burning, or shooting pains in the feet or legs, though pain is often less severe than in some acquired neuropathies.NINDS+1
-
Slow, lifelong progression – Symptoms usually progress slowly over decades. Many people remain able to walk, often with braces or supports, but may need aids as they get older.Charcot-Marie-Tooth Association+1
Diagnostic tests
Doctors diagnose CMT2F by combining the clinical picture, family history, nerve tests, and genetic testing. The aim is to confirm that the neuropathy is length-dependent and axonal, rule out other causes (like diabetes or vitamin deficiency), and identify an HSPB1 mutation.PMC+1
Physical examination tests (examples)
-
Full neurological examination – The doctor checks muscle strength, tone, reflexes, coordination, and sensation. In CMT2F, they often find distal weakness, reduced ankle reflexes, and sensory loss in a “stocking and glove” pattern.Cleveland Clinic+2PMC+2
-
Gait and walking assessment – The doctor watches how the person walks, looking for steppage gait (lifting knees high), tripping, poor heel-to-toe walking, or difficulty walking on heels. These signs suggest foot drop and distal weakness.epocrates.com+1
-
Inspection of feet and hands – The doctor looks at the shape of the feet and hands for high arches, hammertoes, calluses, or hand muscle wasting. These external signs can strongly suggest a long-standing hereditary neuropathy.Muscular Dystrophy Association+1
-
Deep tendon reflex testing – Using a reflex hammer, the doctor taps tendons at the knees and ankles. In many neuropathies, especially CMT, ankle reflexes are reduced or absent, which supports the diagnosis.PMC+2The Foundation for Peripheral Neuropathy+2
-
Motor strength grading (manual muscle testing) – The doctor asks the patient to push or pull against resistance at specific joints (like ankle dorsiflexion, plantarflexion, toe extension, finger abduction). Strength is graded from 0 to 5 and shows which muscles are most affected.Wikidoc+1
-
Romberg balance test – The patient stands with feet together and then closes their eyes. Increased swaying or falling suggests impaired position sense in the feet and is common in length-dependent sensory neuropathies.Physiopedia+1
Manual bedside sensory tests
-
Light touch testing – The doctor lightly touches the skin with cotton wool or a fingertip and asks if the touch is felt. In CMT2F, sensitivity often decreases first in the toes and feet and later in the hands.Wikidoc+1
-
Pinprick testing – A disposable pin or neurotip is gently applied to check pain sensation. Reduced or absent pinprick feeling in the toes and feet shows involvement of small sensory fibers in the peripheral nerves.Medscape eMedicine+1
-
Vibration testing with a 128-Hz tuning fork – A vibrating tuning fork is placed on bony points (like the big toe joint or ankle). Many people with length-dependent neuropathy lose vibration sense early, so they may feel little or nothing at the toes.NCBI+1
-
Monofilament (pressure) testing – A 10-gram monofilament is pressed on the skin of the foot to test pressure sensation. If the person cannot feel the filament at several points, it means protective sensation is reduced, which increases the risk of unnoticed injuries.PMC+1
-
Tinel’s sign over peripheral nerves – The doctor taps gently over a nerve (for example, at the ankle or wrist). In some neuropathies there may be tingling or shooting sensations. While more typical in entrapment neuropathies, this test helps check for co-existing compression problems in people with CMT2F.Physiopedia+1
Laboratory and pathological tests
-
Basic blood tests to rule out other causes – Tests such as fasting blood sugar, vitamin B12, thyroid function, kidney and liver tests, and sometimes autoimmune markers help exclude acquired causes of neuropathy. Normal results support a hereditary cause like CMT2F.PMC+1
-
Genetic testing for HSPB1 mutations – DNA from blood or saliva is analyzed using targeted gene panels or whole exome/genome sequencing. Finding a pathogenic mutation in the HSPB1 gene in someone with a matching clinical picture confirms the diagnosis of CMT2F.MalaCards+1
-
Broader CMT gene panel testing – Sometimes a larger panel of CMT-related genes is tested first. If the HSPB1 mutation is found among them and fits the clinical pattern, it is labeled as CMT2F rather than another CMT subtype.MalaCards+1
-
Nerve biopsy (rarely needed) – A small piece of a sensory nerve (often the sural nerve) is removed and examined under the microscope. In axonal CMT, pathology shows loss of axons with relative sparing of myelin, but today biopsy is usually reserved for unclear or research cases.PMC+1
Electrodiagnostic tests
-
Nerve conduction studies (NCS) – Electrodes are placed on the skin and small electrical impulses are used to measure how fast and how strong signals travel along nerves. In CMT2F, conduction speed is often normal or only mildly slowed, but the response size (amplitude) is reduced, showing axonal damage.MalaCards+2ScienceDirect+2
-
Electromyography (EMG) – A thin needle electrode is inserted into muscles to record electrical activity at rest and during contraction. In CMT2F, EMG typically shows signs of chronic denervation and reinnervation in distal muscles, confirming a chronic axonal neuropathy.MDPI+1
-
Somatosensory evoked potentials (optional) – In some centers, small electrical stimuli are given to peripheral nerves while recordings are made from the spinal cord or brain. Delayed or small responses indicate disrupted sensory pathways. This is more often a research or complex case tool than a routine test.Merck Manuals+1
Imaging tests
-
MRI of brain and spinal cord (for differential diagnosis) – MRI scans are usually normal in CMT2F, but they are useful to rule out other conditions such as spinal cord compression, multiple sclerosis, or motor neuron disease, which can also cause weakness and gait problems.PMC+1
-
Musculoskeletal imaging (X-ray or MRI of feet/ankles) – X-rays or MRI of the feet and ankles can show high arches, hammertoes, and joint changes. These images help orthopedic surgeons plan corrective procedures or braces for people with significant deformities from CMT2F.Muscular Dystrophy Association+1
Non-pharmacological treatments (therapies and others )
1. Physiotherapy and stretching
Physiotherapy is one of the main treatments for Charcot-Marie-Tooth neuronal type 2F. A physiotherapist teaches gentle stretching and low-impact exercises to keep joints moving and muscles flexible. The purpose is to slow down stiffness, prevent contractures, and keep walking as easy as possible. The main mechanism is simple: regular movement keeps muscles from shortening and helps joints stay in a healthy position, which reduces pain and improves balance. Physiopedia+2PMC+2
2. Strengthening and resistance training
Carefully planned strengthening with light weights or elastic bands can help muscles that are still working to stay stronger for longer. The goal is to improve daily function, like climbing stairs or standing from a chair. The mechanism is muscle adaptation: when a muscle works against resistance, the fibers become stronger and more efficient, which can partly compensate for weak nerves, as long as the program is gentle and supervised. Physiopedia+1
3. Balance and gait training
CMT2F often causes poor balance and a high-stepping, unsafe gait. A therapist can train safe walking patterns, turning, and standing on different surfaces. The purpose is to cut the risk of falls and injuries. The mechanism is “neuro-motor learning”: repeating safe movements trains the brain and the remaining nerves to use the available muscles in the best way. PMC+1
4. Ankle–foot orthoses (AFOs)
Ankle–foot orthoses are light braces that hold the ankle and foot in a better position. They help lift the front of the foot (foot drop), prevent tripping, and reduce fatigue. The mechanism is mechanical support: the brace replaces some of the lost muscle power and keeps joints aligned, which makes walking more energy-efficient and safer. Charcot-Marie-Tooth Association+1
5. Custom shoes and insoles
Special shoes and insoles support high arches, claw toes, and unstable ankles that are common in CMT. The purpose is to spread pressure more evenly, prevent skin sores, and make walking more comfortable. The mechanism is redistribution of force: soft, shaped materials under the foot reduce local pressure points and improve balance feedback from the sole. Charcot-Marie-Tooth Association+1
6. Occupational therapy (daily-activity training)
Occupational therapists help people with Charcot-Marie-Tooth neuronal type 2F manage dressing, writing, using phones, and doing work or school tasks. They may teach joint-protection tricks and energy-saving techniques. The mechanism is task adaptation: changing the way an activity is done, or using tools, allows the same task with less stress on weak muscles and joints. PMC+1
7. Hand and wrist splints
Weak hand muscles and finger deformities make gripping hard. Soft or rigid splints and thumb supports can improve pinch and reduce pain. The mechanism is positioning: by holding joints in a stable, functional place, the splint allows the remaining muscle power to work more effectively, which helps with buttons, pens, or keyboards. PMC+1
8. Aquatic (water-based) therapy
Exercise in warm water supports body weight and reduces the risk of falls. People with CMT2F can practice walking, balance, and gentle strengthening in the pool. The purpose is to stay active without overloading weak muscles and joints. The mechanism is buoyancy: water lifts part of the body weight and gives uniform resistance, so movements are smoother and less painful. PMC+1
9. Assistive walking devices (canes, crutches, walkers)
Canes, crutches, or walkers can be used when balance or fatigue becomes a problem. The purpose is to prevent falls and allow longer walking distances. The mechanism is extra support points: the device widens the base of support and shares weight between the legs and the arms, which stabilizes the body during movement. ScienceDirect+1
10. Fall-prevention and home modification
Simple changes at home—removing loose rugs, adding grab bars, using night-lights—can lower the risk of accidents. The purpose is safety in daily life. The mechanism is environmental control: when obstacles and slippery or dark areas are reduced, a person with CMT2F is less likely to trip or lose balance. ScienceDirect+1
11. Podiatry and regular foot care
Because sensation is reduced, small wounds on the feet can be missed. Regular visits to a podiatrist for nail care, callus removal, and shoe advice help prevent ulcers and infections. The mechanism is early detection and load control: checking feet often catches problems when they are still small. Muscular Dystrophy Association+1
12. Pain psychology, CBT, and coping skills
Chronic neuropathic pain and disability can affect mood and sleep. Cognitive-behavioural therapy (CBT) and other psychological approaches teach coping strategies, relaxation, and pacing. The mechanism is brain re-training: changing thoughts and behaviours around pain can lower perceived pain intensity and improve quality of life. Charcot-Marie-Tooth Association+1
13. Energy-conservation and fatigue management
Many people with Charcot-Marie-Tooth neuronal type 2F feel tired easily. Learning to plan the day, rest before exhaustion, and use labour-saving devices helps preserve energy for important tasks. The mechanism is load balancing: spreading activities across the day prevents overuse of weak muscles and reduces flare-ups. PMC+1
14. Vocational and school rehabilitation
Specialists can help adjust work or school tasks, recommend ergonomic chairs, keyboards, or voice-to-text tools, and support disability paperwork when needed. The purpose is to keep the person included in education and employment for as long as possible. The mechanism is adjusting the environment rather than the person, reducing physical demands without losing productivity. PMC+1
15. Breathing and sleep monitoring when needed
In severe cases or in some CMT types, weakness can affect breathing muscles or cause sleep-disordered breathing. Overnight sleep studies and breathing tests may be needed. The mechanism is early detection of respiratory involvement so that treatments like non-invasive ventilation or oxygen can be started before serious complications. ScienceDirect+1
16. Orthopaedic review for foot and spine deformity
Regular checks by an orthopaedic specialist help track high arches, claw toes, and spinal curves. The purpose is to decide the best timing for braces or surgery. The mechanism is structural planning: early intervention, when deformity is flexible, often gives better long-term function than very late surgery. Wikipedia+1
17. Genetic counselling for family planning
Because CMT2F is usually autosomal dominant, each child has about a 50% chance to inherit the variant if one parent is affected. Genetic counsellors explain this risk, testing options, and emotional aspects. The mechanism is informed choice: families can make pregnancy and testing decisions with clear information. MalaCards+1
18. Peer support groups and patient organizations
Support groups, in person or online, connect people living with Charcot-Marie-Tooth diseases. They share tips about aids, doctors, and coping. The mechanism is social support: feeling understood reduces stress and depression and can even improve pain perception. Charcot-Marie-Tooth Association+1
19. Lifestyle measures: quitting smoking and limiting alcohol
Smoking and heavy alcohol use can damage blood vessels and nerves, which may worsen neuropathy. The purpose is to protect the remaining nerve function. The mechanism is risk reduction: removing toxic exposures lowers oxidative stress and small-vessel damage around nerves. Springer+1
20. Healthy-weight and moderate-exercise program
Extra body weight makes walking harder and increases strain on weak ankles and feet. A balanced diet plus low-impact exercise (like cycling or swimming) helps maintain a healthy weight. The mechanism is mechanical relief and better metabolic health, which together reduce stress on the musculoskeletal and nerve systems. PMC+1
Drug treatments
Important: No medicine can cure Charcot-Marie-Tooth neuronal type 2F today. Drugs are used to treat symptoms such as neuropathic pain, muscle cramps, mood problems, or sleep issues. Doses here are taken from adult FDA labels for other neuropathic conditions (like diabetic neuropathy or post-herpetic neuralgia). They are not self-treatment advice. Only a qualified doctor can choose if a drug is appropriate and what dose is safe for a specific patient. FDA Access Data+1
Because of space, each medicine is explained in simple, shorter form rather than full 100-word blocks.
1. Pregabalin (Lyrica)
Pregabalin is an anticonvulsant often used for neuropathic pain. It binds to calcium channels in nerve endings and reduces release of pain-signalling chemicals. For adult diabetic neuropathic pain, labels suggest around 150–300 mg per day in divided doses (up to 600 mg/day in some cases). Common side effects include dizziness, sleepiness, weight gain, and swelling of the legs. In CMT2F it may be used off-label to reduce burning, shooting nerve pain. FDA Access Data+1
2. Duloxetine (Cymbalta)
Duloxetine is a serotonin–noradrenaline reuptake inhibitor (SNRI) antidepressant that also treats neuropathic pain. It boosts certain brain chemicals that help control both mood and pain. For adult diabetic peripheral neuropathic pain, FDA labelling recommends 60 mg once daily. Side effects can include nausea, dry mouth, sleepiness, and sweating. In Charcot-Marie-Tooth neuronal type 2F, duloxetine may help when neuropathic pain and low mood occur together. FDA Access Data+2FDA Access Data+2
3. Gabapentin (Neurontin)
Gabapentin is another anticonvulsant used for neuropathic pain. It reduces abnormal excitability in pain pathways by binding to calcium channel subunits. For adult post-herpetic neuralgia, labels titrate up to about 1800 mg/day in divided doses. Main side effects are dizziness, sleepiness, and ankle swelling. Doctors may use gabapentin off-label to ease chronic nerve pain in CMT2F. FDA Access Data+2FDA Access Data+2
4. Amitriptyline
Amitriptyline is an older tricyclic antidepressant used at low doses to control neuropathic pain and improve sleep. It boosts serotonin and noradrenaline and also blocks some pain channels. Typical adult neuropathic-pain doses start around 10–25 mg at night and may slowly increase. Side effects can include dry mouth, constipation, blurred vision, and sleepiness. It must be used carefully because overdose can be dangerous. Medscape eMedicine+1
5. Nortriptyline
Nortriptyline is a related tricyclic with slightly fewer sedating effects. It has a similar mechanism and is also used at low doses at night to treat nerve pain and improve sleep quality. Usual adult starting doses may be 10–25 mg at bedtime, adjusted by the doctor. Common side effects are dry mouth, dizziness, and constipation. Medscape eMedicine+1
6. Carbamazepine
Carbamazepine is an anticonvulsant that stabilizes over-active nerve membranes by blocking sodium channels. It is well known for trigeminal neuralgia and other neuropathic pains. Adult doses vary widely and must be started low and increased slowly under monitoring. Side effects can include drowsiness, low sodium, liver problems, and rare blood disorders, so regular blood tests are needed. Medscape eMedicine+1
7. Oxcarbazepine
Oxcarbazepine is a newer relative of carbamazepine with similar sodium-channel effects and sometimes a better side-effect profile. It can help some neuropathic pain syndromes, though evidence is mixed. Doses are individualized and always prescribed by a neurologist. Possible side effects include dizziness, nausea, and low sodium. ScienceDirect+1
8. Topical lidocaine 5% patch
Lidocaine patches are applied to painful skin areas. Lidocaine blocks sodium channels in superficial nerves, numbing them and reducing pain signals from the skin. For adult post-herpetic neuralgia, labels allow patches to be worn for up to 12 hours in 24. Common side effects are mild local redness or irritation. In CMT2F they may help focal burning areas without causing whole-body side effects. FDA Access Data+1
9. Capsaicin 8% patch or low-dose cream
Capsaicin (from chili peppers) overstimulates and then “switches down” pain fibers in the skin. High-strength 8% patches are applied in clinic for limited times, while low-dose creams can be used at home. Burning and redness are common at first. It may give longer-term relief in localized nerve pain. ScienceDirect+1
10. Non-steroidal anti-inflammatory drugs (NSAIDs)
Medicines like naproxen or ibuprofen are not very strong for neuropathic pain, but they can help joint and muscle aches in CMT2F. They work by blocking prostaglandin enzymes (COX-1/COX-2), which lowers inflammation and pain. Side effects can include stomach upset, ulcers, kidney strain, and increased bleeding risk, especially with long-term use. ScienceDirect+1
11. Tramadol
Tramadol is a weak opioid with added serotonin-noradrenaline reuptake inhibition. It may be considered for short-term rescue pain control when other medicines are not enough. It acts on opioid receptors and monoamine systems to reduce pain perception. Side effects include nausea, dizziness, constipation, and risk of dependence; it must be used very carefully and often avoided in young people. ScienceDirect+1
12. Baclofen
Baclofen is a muscle relaxant that acts on GABA-B receptors in the spinal cord. In CMT, it may help with painful muscle cramps or spasticity if present. Adult oral doses are titrated up slowly from very low levels. Common side effects include sleepiness, weakness, and dizziness, so dose changes must be gradual. ScienceDirect+1
13. Tizanidine
Tizanidine is another muscle relaxant acting mainly on alpha-2 adrenergic receptors. It reduces increased muscle tone and cramping. It is taken several times per day with careful dose increases. Side effects include low blood pressure, sleepiness, and dry mouth, so monitoring is important. ScienceDirect+1
14. Botulinum toxin injections (for focal problems)
In selected cases with very tight muscles or painful deformities, small doses of botulinum toxin can be injected into overactive muscles. It blocks acetylcholine release at the neuromuscular junction, temporarily weakening those muscles. Effects last about 3–4 months. It must be given by experienced specialists. Mayo Clinic+1
15. Serotonin-noradrenaline reuptake inhibitors (other than duloxetine)
Medicines like venlafaxine also increase serotonin and noradrenaline in the brain and spinal cord and can help some neuropathic pains. Doses and side effects are similar to antidepressant use: nausea, increased blood pressure, and sleep changes. Doctors choose them when duloxetine is not suitable or not enough. PubMed+1
16. Selective serotonin reuptake inhibitors (SSRIs)
SSRIs such as sertraline or fluoxetine mainly treat depression and anxiety, which are common in chronic illness. While their direct effect on neuropathic pain is weaker than SNRIs or tricyclics, better mood and sleep can reduce how painful symptoms feel. Side effects include stomach upset and sleep disturbance. Wiley Online Library+1
17. Sleep medicines (short-term, specialist-guided)
Severe pain or cramps can disturb sleep. Occasionally, short-term sleep medicines (like certain non-benzodiazepine hypnotics or melatonin) may be used. They act on brain receptors that control sleep cycles. Because of risks like dependence or daytime drowsiness, they are used at the lowest effective dose and for limited time. PubMed
18. Vitamin B12 (when deficient)
Vitamin B12 itself does not cure CMT2F, but deficiency of B12 can cause an additional neuropathy. In people with low B12 levels, injections or tablets can improve nerve symptoms and prevent further damage. The mechanism is support of myelin and DNA production in nerves. Side effects are usually mild. The Foundation for Peripheral Neuropathy+1
19. Multivitamin B-complex (for proven deficiency states)
In cases where nutritional neuropathy co-exists (for example from poor diet or alcohol use), a B-complex with thiamine, B6, folate, and B12 can be prescribed. These vitamins help energy production and myelin repair. They do not reverse genetic CMT2F but may improve overlapping nutritional nerve damage. Springer+1
20. Clinical-trial investigational drugs
Several experimental drugs are being studied for other CMT types (for example CMT1A) and other axonal neuropathies. They may work on pathways like myelin production, axonal transport, or mitochondrial function. Doses and safety are determined only inside clinical trials. Anyone interested should discuss research options with a neurologist or CMT specialist and never use unapproved products from non-regulated clinics. ScienceDirect+1
Dietary molecular supplements
Note: Evidence for supplements in genetic neuropathies like CMT2F is limited. Most data come from diabetic or toxic neuropathy. Always discuss supplements with a doctor, especially if you take other medicines. PubMed+1
1. Alpha-lipoic acid (ALA)
Alpha-lipoic acid is an antioxidant that helps fight oxidative stress in nerves. Studies in diabetic neuropathy used oral doses around 600 mg/day and showed moderate symptom relief. It may improve nerve blood flow and reduce harmful free radicals, which can protect nerve fibers. Side effects can include stomach upset or skin rash. PubMed+2MDPI+2
2. Acetyl-L-carnitine (ALC)
Acetyl-L-carnitine helps transport fatty acids into mitochondria, the “power plants” of cells. Trials in peripheral neuropathy show moderate pain reduction and some improvement in nerve regeneration with doses often between 1,000–3,000 mg/day in divided doses. It seems to support energy production in damaged nerves. Side effects are usually mild, such as nausea. PMC+2PLOS+2
3. Omega-3 fatty acids (fish oil)
Omega-3 fats from fish oil have anti-inflammatory and membrane-stabilizing effects. While data in CMT2F are limited, omega-3s support general nerve and brain health and may reduce chronic inflammation. Typical supplement doses are 1–3 g/day of EPA+DHA, adjusted by the doctor. Main side effects are fishy aftertaste and, at high doses, a small increase in bleeding risk. PMC+1
4. B-complex vitamins
Thiamine, B6, folate, and B12 are important for nerve metabolism and myelin. In deficiency states, B-complex supplementation can improve neuropathy and prevent progression. Doses vary widely depending on blood levels and medical guidance. Mechanism: they help energy production, neurotransmitter synthesis, and myelin repair. The Foundation for Peripheral Neuropathy+2MedLink+2
5. Vitamin D
Vitamin D supports bone health, immune modulation, and possibly nerve function. Low vitamin D is common in chronic illness. Correcting deficiency with doses chosen by a doctor (often 800–2,000 IU/day, sometimes higher short-term) supports overall musculoskeletal health, which is important when muscle weakness is present. MedLink+1
6. Magnesium
Magnesium is involved in nerve conduction and muscle relaxation. In some people it may reduce cramps or restless legs. Dosage is usually in the 200–400 mg/day range of elemental magnesium, depending on kidney function. Too much can cause diarrhoea or, rarely, serious heart rhythm problems in kidney disease, so medical advice is needed. MedLink
7. Coenzyme Q10 (CoQ10)
CoQ10 is part of the mitochondrial energy chain and an antioxidant. It may support muscles and nerves by improving energy supply and reducing oxidative stress, although evidence in CMT is limited. Typical supplement doses fall between 100–300 mg/day. Side effects are usually mild, like stomach discomfort. PMC+1
8. Curcumin (turmeric extract)
Curcumin has anti-inflammatory and antioxidant effects. Some studies in metabolic disease show reduced inflammatory markers. It may theoretically protect nerves from chronic inflammation. Absorption is poor unless combined with piperine or special formulations. Doses vary; too much may cause stomach upset or interact with blood-thinning medicines. PMC+1
9. Gamma-linolenic acid (GLA)
GLA is an omega-6 fatty acid found in evening primrose or borage oil. Trials in diabetic neuropathy suggest possible benefit similar to ALA in some people. Doses of 240–480 mg/day of GLA are typical. Mechanism: it is converted into anti-inflammatory prostaglandins, which may help nerve micro-circulation. E-DMJ+1
10. Antioxidant-rich Mediterranean-style diet instead of high-dose pills
Rather than many pills, many experts recommend a Mediterranean-style diet rich in fruits, vegetables, olive oil, nuts, and whole grains to provide natural antioxidants and anti-inflammatory nutrients. This pattern supports vascular and brain health and may indirectly help neuropathy. PMC+2Blue Ridge Acupuncture+2
Regenerative, immunity-related, and stem-cell-type therapies
Today there are no approved stem cell or gene therapies specifically for Charcot-Marie-Tooth neuronal type 2F. Research is ongoing, but everything in this section is experimental and must only be done in regulated clinical trials, not private “stem cell clinics.” ScienceDirect+1
1. Gene-targeted therapies (research stage)
Scientists are studying ways to fix or silence disease genes in CMT, using tools like antisense oligonucleotides or viral gene therapy. For CMT2F this might mean targeting HSPB1 in the future. At present there is no standard drug, dose, or approved product; all work is in labs or early trials. ScienceDirect+1
2. Neurotrophic growth factors
Molecules such as neurotrophin-3 have been tested in some hereditary neuropathies to see if they can support nerve survival and regrowth. Results so far are mixed, and side effects and delivery methods remain problems. Again, there is no approved growth-factor drug for CMT2F. ScienceDirect+1
3. Stem-cell transplantation research
Different stem-cell types (for example mesenchymal stem cells) are being explored in animal models of neuropathy to see whether they can release helpful growth factors or become support cells. Human studies are small and experimental. No safe standard dose, route, or long-term result is established for CMT2F. ScienceDirect+1
4. Immunomodulatory drugs in overlap conditions
If a person with CMT2F also has an autoimmune neuropathy component, doctors may sometimes use immune drugs such as IVIG or steroids. These do not treat the genetic part of CMT2F but may help the autoimmune part. Doses follow autoimmune-neuropathy guidelines and must be specialist-supervised. ScienceDirect+1
5. Experimental metabolic and mitochondrial drugs
Some trials in other neuropathies are testing compounds that support mitochondrial function or reduce toxic metabolites. Examples include certain antioxidants or metabolic modulators used only in trials. For CMT2F there is no approved product yet, so participation in monitored research is the only safe way. arXiv+1
6. Vaccination and standard immune health
The best “immune booster” for someone with CMT2F is staying up to date on routine vaccines and overall health checks. Preventing infections reduces hospital stays, deconditioning, and falls. There are no special extra immune drugs recommended just because of CMT2F; standard preventive care is usually enough. atria.org+1
Surgeries
1. Foot osteotomy (bone reshaping)
In severe high-arched (cavus) feet, surgeons may cut and reshape foot bones to place the foot flatter on the ground. The aim is to improve balance, reduce pain, and allow better fitting of shoes and braces. Osteotomy changes the mechanical alignment so forces are spread more evenly when walking. Wikipedia+1
2. Tendon transfer for foot drop
When the muscles that lift the foot are very weak, a stronger tendon (for example from another leg muscle) can be moved to help lift the front of the foot. The purpose is to correct foot drop and reduce tripping. The mechanism is re-routing muscle power from a less important movement to a more important one. Wikipedia+1
3. Ankle fusion (arthrodesis)
If the ankle is very unstable or painful despite braces, joints can be fused so bones grow together and no longer move. This sacrifices some ankle motion but gives a stable platform for walking. It is usually considered after bracing and less invasive options fail. Wikipedia+1
4. Plantar fascia and soft-tissue releases
Tight tissues under the foot or around the toes can be surgically lengthened or released. This reduces claw toes or very high arches that cause pressure sores. The mechanism is releasing tight bands so the foot can sit more normally in shoes or braces. Wikipedia+1
5. Spinal surgery for scoliosis
Some people with long-standing neuromuscular weakness develop spinal curvature (scoliosis). If curves become severe and painful or affect breathing, spinal fusion with rods may be offered. The goal is to stabilize the spine, improve sitting balance, and protect lung function. Wikipedia+1
Preventions
-
Avoid nerve-toxic drugs and heavy alcohol – Some chemotherapy drugs, very high alcohol intake, and certain medicines can damage peripheral nerves; your doctor can review your medication list. Wikipedia+1
-
Protect feet every day – Check the skin, wear closed, cushioned shoes, and avoid walking barefoot to prevent unnoticed injuries. Muscular Dystrophy Association+1
-
Keep up regular physiotherapy and home exercises to maintain strength, flexibility, and balance. PMC+1
-
Use braces and aids early, not late, so walking is safe and efficient and falls are less likely. Charcot-Marie-Tooth Association+1
-
Maintain a healthy body weight with a balanced diet to reduce stress on weak feet and ankles. PMC+1
-
Stop smoking to improve circulation to nerves and muscles. Springer+1
-
Control other health problems such as diabetes, thyroid disease, or vitamin deficiencies that can add extra neuropathy. The Foundation for Peripheral Neuropathy+1
-
Make the home fall-safe by removing clutter, adding grab bars, and using good lighting. Mayo Clinic+1
-
Attend regular specialist follow-up with a neurologist and orthopaedic team to catch new problems early. ScienceDirect+1
-
Seek emotional and social support to reduce stress, depression, and isolation, which can worsen pain and fatigue. Charcot-Marie-Tooth Association+1
When to see doctors
You should see a doctor or neuromuscular specialist if you notice:
-
New or fast-worsening weakness, especially if you suddenly cannot walk safely or lift your feet. ScienceDirect
-
New falls, loss of balance, or injuries from tripping. ScienceDirect+1
-
Severe burning, stabbing, or electric-shock-like pain that simple measures do not control. Charcot-Marie-Tooth Association+1
-
Changes in breathing (shortness of breath lying flat, morning headaches) or swallowing. ScienceDirect+1
-
Rapid change in foot or hand shape, or painful pressure areas or wounds on the feet. Muscular Dystrophy Association+1
-
Mood problems like persistent sadness, anxiety, or thoughts of hopelessness; these are medical issues and deserve care. PubMed
Because you are a teenager, it is especially important to involve your parents or guardians and your doctor before starting or changing any medicine or supplement.
What to eat and what to avoid
What to eat (5 items)
-
Plenty of colourful vegetables and fruits – They provide antioxidants and vitamins that support general nerve and brain health and fight inflammation. PMC+1
-
Healthy fats such as olive oil, nuts, and seeds – Mediterranean-style fats support blood vessels and may protect the nervous system. PMC+2atria.org+2
-
Fish rich in omega-3 (like salmon or sardines) – Omega-3 fats have anti-inflammatory and neuroprotective effects. PMC+1
-
Whole grains and legumes – They give steady energy and important B vitamins needed for nerve function. MedLink+1
-
Adequate protein (beans, eggs, dairy, lean meat if used) – Protein supports muscle repair and strength, which is essential when muscles are weak from CMT2F. PMC+1
What to avoid or limit (5 items)
-
Heavy alcohol – It can directly damage nerves and worsen neuropathy, so it should be avoided. Springer+1
-
Very high-sugar, ultra-processed foods – These can worsen weight gain and metabolic problems, indirectly stressing nerves and joints. PMC+1
-
Highly salted and deep-fried foods – They increase cardiovascular risk, which is unhelpful for already-stressed nerves and muscles. PMC+1
-
Extreme crash diets or unbalanced “nerve cure” diets – These can cause vitamin deficiencies that add a second neuropathy on top of CMT2F. The Foundation for Peripheral Neuropathy+1
-
Unproven “miracle” supplements from the internet – Some may interact with medications or be unsafe; always check with a doctor first. Wikipedia+1
FAQs
1. Is Charcot-Marie-Tooth neuronal type 2F curable?
No. At the moment there is no cure that can remove the gene change in HSPB1 or fully stop the disease. Treatment focuses on symptoms, protection of function, and quality of life. Research on gene and regenerative therapies is ongoing, but nothing is yet approved for everyday use. MalaCards+1
2. How is CMT2F different from CMT1?
CMT1 is mainly a demyelinating neuropathy, which means the “insulation” around the nerve fiber is mostly damaged. CMT2F is an axonal neuropathy, so the main damage is in the long central “wire” of the nerve. Nerve conduction tests often show near-normal speeds but reduced signal size in CMT2F. ScienceDirect+1
3. What gene is involved in CMT2F?
Most known cases of CMT2F are caused by mutations in the HSPB1 gene, which encodes a small heat-shock protein that protects nerve cells from stress. A faulty protein makes axons more likely to degenerate over time. MalaCards+1
4. At what age does CMT2F usually start?
CMT2F can start in the teenage years, young adulthood, or later adult life. Symptoms usually progress slowly over many years, but the exact age and speed vary even within the same family. MalaCards+1
5. Is it safe to exercise with CMT2F?
Yes, in general gentle, supervised exercise is not only safe but recommended. Low-impact activities, stretching, and strengthening can keep you mobile. Over-intense, painful exercise that causes lasting fatigue should be avoided; a physiotherapist can design a safe plan. Physiopedia+2ScienceDirect+2
6. Will I end up in a wheelchair?
Some people with CMT2F may need a wheelchair for long distances after many years, while others walk with braces all their lives. Early therapy, bracing, and fall-prevention can delay or reduce the need for a wheelchair. Every person’s path is different. ScienceDirect+1
7. Can medicines stop the disease from getting worse?
Current medicines treat symptoms such as pain, cramps, or depression, but do not stop the underlying axonal degeneration. Taking medicines as prescribed, plus therapy, may still greatly improve daily comfort and function. Muscular Dystrophy Association+2Medscape eMedicine+2
8. Is CMT2F life-threatening?
Most people with CMT2F have a normal life span. The main problems are disability, pain, and risk of falls. Life-threatening complications are uncommon but can occur if severe scoliosis or respiratory muscle weakness develops; regular follow-up is important. ScienceDirect+1
9. Can children or teenagers have CMT2F?
Yes. Because it is genetic, signs can appear in adolescence or even childhood, such as frequent tripping, high arches, or weak ankles. Early diagnosis allows timely physiotherapy and bracing to protect joints. MalaCards+1
10. Can diet cure my neuropathy?
Diet alone cannot cure a genetic neuropathy like CMT2F, but a healthy pattern such as the Mediterranean-style diet supports general nerve and brain health and prevents extra nutritional neuropathies. Think of food as support, not as a stand-alone cure. PMC+2The Foundation for Peripheral Neuropathy+2
11. Should I take alpha-lipoic acid or acetyl-L-carnitine?
These supplements have some evidence in diabetic or chemotherapy-related neuropathy, but not specifically in CMT2F. They may help pain a little in some people, but they are not magic cures and can have side effects. Any supplement should be discussed with your doctor and checked for interactions. PubMed+2PLOS+2
12. Is it safe to try stem cell treatment abroad?
Unregulated private “stem cell clinics” are often expensive and risky and have no proven benefit for Charcot-Marie-Tooth diseases at this time. Safe stem cell or gene therapy must be done only inside approved clinical trials. ScienceDirect+1
13. Can pregnancy make CMT2F worse?
Some women with CMT report more weakness or falls during pregnancy because of weight gain and hormonal changes, while others notice little change. Planning pregnancy with a neurologist and obstetrician allows closer monitoring and safety planning. ScienceDirect+1
14. How can my family be tested?
If a disease-causing HSPB1 variant is found in one person, close relatives can have targeted genetic testing after counselling. This helps clarify who carries the gene and who does not, but accepting or declining testing is always a personal choice. MalaCards+1
15. What is the single most important thing I can do now?
For most people with Charcot-Marie-Tooth neuronal type 2F, the most powerful steps are: regular physiotherapy, appropriate braces, safe home set-up, healthy lifestyle (diet, no smoking, limited alcohol), and regular follow-up with a neuromuscular specialist. Together, these protect function and independence over many years. PMC+3Physiopedia+3Charcot-Marie-Tooth Association+3
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December 22, 2025.